News & information from the Infectious Diseases Society of America, a community of 13,000+ physicians, scientists & public health experts who specialize in ID.
Congratulations to
@PeterHotez
, MD, PhD, the recipient of IDSA’s 2023 Anthony Fauci Courage in Leadership Award. Dr. Hotez’s exemplary career has been rooted in speaking scientific truth, perseverance in the face of opposition and serving as a change agent for the most vulnerable
IDSA &
@PIDSociety
support
@US_FDA
&
@CDCgov
decisions to authorize the Pfizer-BioNTech COVID-19 vaccine for children aged 5-11 years. Vaccination will provide these children w/ critical protection against serious disease & hospitalization & strengthen immunity in the community.
IDSA and
@HIVMA
call for the immediate reversal of the abrupt revision of the CDC COVID-19 testing guidelines which diminish the importance of testing asymptomatic individuals who were exposed to COVID-19.
Our statement:
Updated
#IDSAGuidelines
! IDSA has released updated guidelines on the treatment of antimicrobial-resistant gram-negative infections:
This update focuses on infections caused by Extended-spectrum β-lactamase producing Enterobacterales (ESBL-E), AmpC
Antimicrobial resistance threatens our health, our environment, our livelihoods and our future.
Unless we act now and together, the ripple effects of drug resistance will be felt across generations, jeopardising the wellbeing of our children and our grandchildren.
IDSA has released NEW guidance on treating infections caused by three of the most common drug-resistant pathogens:
• AmpC-E
• CRAB
• S. maltophilia
Guidelines:
Press release:
#IDSAGuidelines
#WAAW21
Promoting the concept of “herd immunity” as an answer to COVID-19 is inappropriate, irresponsible & ill-informed.
We strongly denounce the “declaration" that states this crisis can be controlled in the absence of critical public health measures.
NEW: IDSA Guidelines on the Treatment & Management of Patients with COVID-19 Infection. These evidence-based rapid guidelines, updated in real-time, will address pressing clinical questions related to caring for patients w/ COVID-19:
#COVID19Guidelines
As ID physicians on the front line of combating the current global crisis, we stand strongly against
@POTUS
's decision to leave
@WHO
. We will not succeed against this pandemic, or any future outbreak, unless we stand together, share information, and coordinate actions.
#Ivermectin
has not been proven to treat COVID-19, and it can cause harm.
The doses needed to possibly work against COVID-19 in a test tube are 50-100x HIGHER than current recommended doses, an amount not safe in humans.
#IvermectinIsNotForCOVID
📄:
Reports of a campaign to discredit and diminish the role of Dr. Fauci at this perilous moment are disturbing. If we have any hope of ending this crisis, all of America must support public health experts, including Dr. Fauci, and
#StandWithScience
.
#AmericaNeedsFauci
IDSA has released new guideline recommendations on the use of
#ivermectin
in hospitalized patients and outpatients for the Treatment & Management of Patients with COVID-19.
📄:
#COVID19Guidelines
CID: In respiratory aerosols emitted by COVID-19 patients, fine aerosols produced by talking and singing contained more copies of SARS-CoV-2 than coarse aerosols and may play a significant role in SARS-CoV-2 transmission.
📄:
#IDSAJournals
@drkristenkc
John Bartlett, M.D., FIDSA, a beloved leader of IDSA, passed away on Jan. 19 at the age of 83. An HIV specialist & leading ID physician, Dr. Bartlett was a trailblazer & empathetic steward of science. He will be deeply missed.
#WeAreID
Dr. Bartlett's bio:
Antibody testing for SARS-CoV-2 should not be used as a sole source of diagnosis. IDSA has developed a
#COVID19
antibody testing primer for policymakers, scientists & clinicians to drive research & appropriate use of serologic testing.
📄:
“We are disappointed in
@WhiteHouse
’s decision to abandon the
@WHO
. It is hard to downplay how significant and short-sighted this action is.” IDSA President Thomas File, M.D., FIDSA (
@theIDFile
)
We congratulate President-elect
@JoeBiden
and look forward to working with his transition team members and administration as they take on the public health crisis facing our country.
It's time for our response to this pandemic to bring us together.
IDSA supports the continued collection of data in randomized clinical trials to better understand the benefits of
#convalescentplasma
treatment before authorizing its wider use in patients with
#COVID19
.
In hospitalized patients with severe COVID-19, the IDSA panel suggests against ivermectin use outside of the context of a clinical trial.
In outpatients with COVID-19, the IDSA panel suggests against ivermectin use outside of the context of a clinical trial.
The plan for distributing
#remdesivir
should be transparent and based on state and regional
#COVID19
case data and hospitalization rates.
Our letter to
@VP
:
IDSA and its members have experienced firsthand Dr. Jeanne Marrazzo’s effective, engaging and visionary leadership through her many years of service on the Board of Directors.
We applaud the selection of
@DrJeanneM
to lead
@NIAIDNews
and look forward to working with her on
#Bacteria
found in urine doesn’t always indicate infection, &
#antibiotics
aren’t always the solution, according to IDSA’s guideline for the management of asymptomatic bacteriuria. Learn more:
#IDSAGuidelines
Dr.
@ErinMcCreary
, director of stewardship innovation at
@UMPC
, is one of our two Clinical Practice Innovation Awardees.
As host of the popular Breakpoints podcast, she shares cutting-edge information about ID therapeutics with speed & expertise.
#IDSASocietyAwards
Reports that
@WhiteHouse
has established a procedure that would remove
@CDCgov
as a recipient of data on patients hospitalized w/
#COVID19
are troubling &, if implemented, will undermine our nation’s public health experts.
Our response:
#StandWithScience
NEW GUIDELINES: IDSA releases infection prevention guidelines for health care personnel caring for patients with suspected or confirmed COVID-19:
These guidelines will be frequently updated as substantive literature becomes available.
#COVID19Guidelines
Over 70% of COVID-19 patients in an NYC hospital during March-May were given antibiotics, despite only a small % actually having coexisting bacterial infection.
Antibiotic misuse during COVID-19 could be fueling antibiotic resistance, warns
@ClancyNeil
.
IDSA is pleased to announce our partnership w/
@febrilepodcast
! Febrile uses consult questions to dive into ID clinical reasoning, diagnostics and antimicrobial management.
We look forward this partnership and expanding awareness about the field of ID.
#ValueofID
Among hospitalized adults w/ progressive severe or critical COVID-19 who have elevated markers of systemic inflammation, the IDSA guideline panel suggests
#tocilizumab
in addition to standard of care (i.e. steroids) rather than standard of care alone.
📄:
Positive antibody tests do not mean immunity & are not a green light to abandon social distancing, warns IDSA Board Member Angela Caliendo, MD, FIDSA of
@BrownMedicine
.
"Anything that's done between walls indoors is high-risk, no matter how you slice it, no matter how you tent it," says IDSA spokesperson Dr. Peter Katona in response to restaurant patrons being moved indoors for the winter season.
@HealthDayTweets
The ability to make decisions about the full range of safe reproductive services must remain with the patient and their health care providers.
IDSA and
@HIVMA
condemn the U.S. Supreme Court’s decision to overturn Roe v. Wade:
A new study in JID found that children can carry high viral loads of SARS-CoV-2 regardless of COVID-19 severity or symptoms, suggesting that kids are potential spreaders of SARS-CoV-2 and emerging variants:
#IDSAJournals
#JInfectDis
FL Surgeon General’s recommendation against COVID-19 vaccination for healthy children flies in the face of the best medical guidance, furthering distrust in vaccines proven to be safe & effective against severe COVID-19 disease, hospitalization & death.
📄
A randomized trial reported in CID found that fosfomycin was noninferior to ciprofloxacin as oral stepdown treatment for febrile urinary tract infections in women caused by E. coli.
📄:
#IDSAJournals
#ClinInfectDis
@MarcBonten
New in JID: mRNA vaccines reduced the risk of COVID-19 hospitalization by >95% in healthy adults without chronic medical conditions regardless of age, sex, obesity, or race/ethnicity.
#JInfectDis
#IDSAJournals
A study in CID suggests that practices such as ventilation, filtration and humidification substantially reduce SARS-CoV-2 aerosol viral load and should be prioritized to improve building health and safety.
📄:
#IDSAJournals
@wymelenberg
@HoomanParhizkar
IDSA commends
@GovHerbert
for taking this critical step toward getting the COVID-19 outbreak in Utah under control.
We urge all governors who have not yet enacted mask mandates to do so.
#MaskUpAmerica
Congratulations to Jacinda Abdul-Mutakabbir, PharmD, MPH (
@JayCdoesID
), the recipient of IDSA’s 2023 Clinical Practice Innovation Award.
IDSA is proud to recognize Dr. Abdul-Mutakabbir for her grassroots work to serve historically marginalized communities and amplify the
OFID: In high-risk hematological patients w/ febrile neutropenia, antibiotic de-escalation and discontinuation prior to neutrophil recovery did not lead to an increase in infectious complications.
#IDSAJournals
@PaulSaxMD
@DrJLi
@FungalDoc
@jobadd
Congratulations to IDSA Treasurer
@hboucher3
who has been named dean ad interim for
@TuftsMedSchool
and chief academic officer for
@Wellforce
, beginning July 1. She will be the first woman to lead the School of Medicine in its 128-year history:
#WeareID
IDSA President Carlos del Rio, MD, FIDSA (
@CarlosdelRio7
) was recently honored by U.S. Senator Jon Ossoff (
@ossoff
) for his service to the state of Georgia.
Only about 10% of Americans have been vaccinated, & many of those at greatest risk have yet to receive a vaccine. Abandoning measures such as masking & social distancing will postpone the day we can put COVID-19 behind us.
Public health support is needed:
Over 15M cases of the
#flu
have been reported so far this season. While the novel
#coronavirus
has received widespread media attention, it’s the flu that healthcare providers say you should be more concerned about.
#VaccinesWork
#WhyIVaccinate
#2019nCoV
New microbiology lab diagnosis of infectious disease guide from IDSA and
@ASMicrobiology
helps health care providers know what tests to order and when.
#ClinInfectDis
New
#IDSAGuidelines
! IDSA &
@SCCM
have updated recommendations for evaluating new fever in adult patients in the ICU using GRADE.
Designed for multidisciplinary teams, the guidelines aid in managing critically ill patients.
Learn more:
NEW
#IDSAGuidelines
on the treatment of antimicrobial resistant gram-negative infections! This fourth updated guidance document focuses on infections caused by:
• Extended-spectrum β-lactamase-producing Enterobacterales
• AmpC β- lactamase-producing Enterobacterales
•
OFID: In high-risk hematological patients w/ febrile neutropenia, antibiotic de-escalation and discontinuation prior to neutrophil recovery did not lead to an increase in infectious complications.
📄:
#IDSAJournals
@PaulSaxMD
@DrJLi
@FungalDoc
@jobadd
Let’s showcase the value of the ID community. Help us recognize ID heroes by sharing a
#COVID19
frontline story, a photo of your team, or just a few simple words of encouragement.
#WeAreID
New in OFID: A retrospective study of ~10,000 hospitalized COVID-19 patients found a significant reduction in mortality among those who received ondansetron during the first 2 days of admission.
📄:
#IDSAJournals
@PaulSaxMD
@DrJLi
@Bitscopic
Updated recommendations (see thread below👇) on the use of COVID-19
#convalescentplasma
, neutralizing antibodies and remarks on
#remdesivir
are now available in IDSA's COVID-19 Treatment and Management Guideline:
OFID: In 183 recovered COVID-19 patients, about 10% had persistent symptoms up to 6 months later. Independent of symptoms, all had cytokine profiles suggestive of ongoing chronic inflammation & angiogenesis.
📄:
#IDSAJournals
@seanongwx
@PaulSaxMD
@DrJLi
A new CID commentary signed by 239 experts calls on public health organizations to recognize the potential for airborne transmission of
#COVID19
and urges preventive measures.
#IDSAJournals
#ClinInfectDis
IDSA and
@HIVMA
are deeply saddened by the passing of Adaora Adimora, MD, MPH, FIDSA.
Dr. Adimora exemplified the difference a single person can make in the world. She was an extraordinary leader, infectious diseases physician, researcher, mentor, advocate, and colleague
Vaccination after COVID-19 infection significantly improves protection from reinfection & hospitalization.
IDSA supports
@CDCgov
recommendation that unvaccinated people previously infected w/ SARS-CoV-2 get vaccinated after they've fully recovered.
IDSA recently sent these sweet e-Creamery treats to ID hero Dr. Anthony Fauci, FIDSA as he recovers from vocal cord surgery.
As
@josh_nosanchuk
said best,
#WeAreID
and we need his strong voice!
#AmericaNeedsFauci
Patients with serious infections who are cared for by an ID physician have better outcomes, shorter hospital stays & lower healthcare costs, shares
@RepRaulRuizMD
during today's
@HouseAppropsGOP
and
@AppropsDems
"Member Day" hearing.
Thank you for your leadership in urging
In response to the
#measlesoutbreaks
, The Journal of Infectious Diseases (JID) has curated a collection of articles dedicated to measles vaccination & elimination. All articles will be freely accessible through 9/30.
#IDSAJournals
#JInfectDis
#VaccinesWork
ID specialists are urging law enforcement to stop using tear gas to dispel protest crowds. IDSA member Dr. Peter Chin-Hong (
@PCH_SF
) explains why it can fuel COVID-19 transmission.
Following a transformative year in ID, medicine & science, the time is now to prepare for the future of
#publichealth
.
IDSA &
@CDCgov
are pleased to announce the 11 ID programs selected for the 1st Joint ID/CDC Epidemic Intelligence Service Fellowship.
#IDEISFellowship
A vaccinated person is 8x less likely to get infected with the Delta variant of COVID-19, 25x less likely to be hospitalized, and 25x less likely to die from COVID explains IDSA member Dr.
@rfrancomd
.
Watch our full briefing:
Clinicians and researchers who focus on combatting infectious diseases are grateful for the leadership and contributions of Dr. Rochelle Walensky (
@RWalensky
) during her tenure leading the
@CDCgov
. She took on the challenge of leading the nation’s public health agency at a
.
@POTUS
’s suggestions that restrictions on gathering & travel may be lifted by a specified date are deeply concerning. Following public health and medical evidence during
#COVID19
spread is important to protecting our country’s health and economy.
A new modeling study in JID suggests that once measures to control COVID-19 are relaxed, potentially large outbreaks of influenza may occur, highlighting the need for health systems to prepare & for high rates of influenza vaccination.
📄:
#IDSAJournals
Update Alert: IDSA releases three new recommendations to the Treatment and Management Guideline.
📄:
#COVID19Guidelines
Recommendations explained below 👇
IDSA and
@HIVMA
recently approved a position statement supporting universal removal of the slur “red man syndrome” from written and verbal communications and replacing it with “vancomycin infusion reaction,”.
Read the full statement:
OFID: A review of postmortem studies found that 32% of patients with COVID-19 had lung histopathology consistent w/ potential bacterial superinfections; these infections were responsible for only 3% of deaths.
#IDSAJournals
@PaulSaxMD
@DrJLi
@clancyneil
New in OFID: A multicenter retrospective observational cohort study found no difference in treatment failure or mortality between MRSA bloodstream infections treated with ceftaroline or daptomycin.
📄:
@PaulSaxMD
@DrJLi
@FungalDoc
@IDpharmresearch
OFID: Patients who inject drugs & have serious related infections and request to be discharged had high rates of adherence to oral antibiotics & similar outcomes to those who completed inpatient IV antibiotics.
📄:
@PaulSaxMD
@DrJLi
@FungalDoc
@LauraMarks5
Antibiotic-resistant infections led to $1.9 billion in health care costs, >400,000 days in the hospital & >10,000 deaths among older adults across the U.S. in 2017, reveals new data published today in CID, highlighting the urgent need for federal action:
Infectious Diseases Society of America: "Promoting the concept of 'herd immunity'... as an answer to the COVID-19 pandemic is inappropriate, irresponsible and ill-informed."
False negatives are possible with any medical test. Even if you test negative for
#COVID19
, health experts advise quarantining if your symptoms are consistent with COVID-19. IDSA Secretary Angela Caliendo, MD, FIDSA comments.
IDSA is pleased to announce that Cynthia L. Sears, MD, FIDSA, professor of medicine and oncology at
@HopkinsMedicine
& professor of molecular microbiology and immunology at
@JohnsHopkinsSPH
, has been selected as the next editor-in-chief of The Journal of Infectious Diseases.
For patients with bloodstream infections, treatment with a β-lactam antibiotic before vancomycin may reduce early mortality, a new multicenter, observational study in CID suggests:
#IDSAJournals
#ClinInfectDis